Fundraising Fox
🦊/Companies
Sign in

Nextwavepharma

Acquired

New Jersey, US · 3 known investors

Find your way into Nextwavepharma

Nextwave Pharma markets Quillivant XR, a prescription central nervous system stimulant used to treat Attention Deficit Hyperactivity Disorder (ADHD) in children ages 6 and older. The product is a liquid medication taken orally and is a federally controlled substance.

BiotechHealthtech

Investors · 3

Bay City CapitalSan Rafael · $5M – $10M
F-Prime CapitalCambridge · $3M – $10M
Sofinnova VenturesMenlo Park · $100K – $15M

Frequently asked questions

What does Nextwavepharma do?
Nextwave Pharma markets Quillivant XR, a prescription central nervous system stimulant used to treat Attention Deficit Hyperactivity Disorder (ADHD) in children ages 6 and older. The product is a liquid medication taken orally and is a federally controlled substance.
Who are Nextwavepharma's investors?
Nextwavepharma's investors include Bay City Capital, F-Prime Capital, Sofinnova Ventures.
Where is Nextwavepharma headquartered?
Nextwavepharma is headquartered in New Jersey, US.